Rebalix
UBS · sheet of 10 September 2026
UBS · sheet of 10 September 2026ETF sheet · official issuer and register data
UBS MSCI ACWI Universal UCITS ETF hCHF dis
IE00BDQZN667 · IE00BDQZN667 · CHF · domicile Ireland
EquityCHF-hedged share classSFDR art. 8
Index tracked: MSCI ACWI Universal Low Carbon Select 5% Issuer Capped with Developed Markets 100% Hedged to CHF Index (Net Total Return)
- TER
- 0.26%+ trans. 0.00%
- Fund size
- —
- Tracking difference
- +0.00%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical
- Income
- Distributingsemi-annual
Launch 19 Dec 2017 · costs from the KID as of 26 Aug 2026
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 2 Sept 2026
Il Fondo è a gestione passiva e mira a replicare la performance dell'indice MSCI ACWI Universal Low Carbon Select 5% Issuer Capped with Developed Markets 100% Hedged to CHF Index (Net Total Return) (l'«Indice»).
L'Indice è concepito per misurare la performance di una strategia d'investimento che, discostandosi dalle ponderazioni sulla base della capitalizzazione di mercato corretta per il flottante libero, cerca di ottenere un'esposizione a società che dimostrano sia un ragguardevole profilo ambientale, sociale e di governance (ESG) sia una tendenza…
Performance since series start (in euro) — base 100
19 Dec 2017 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +19.2% |
| 3 years | +60.0% |
| 5 years | +66.3% |
| 10 years | series too young |
| Since series start | +165.6% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 11.50% | 12.11% | 13.62% |
| Max drawdown | −9.16% | −17.31% | −26.89% |
| Sharpe | 1.32 | 0.94 | 0.33 |
| Sortino | 1.93 | 1.31 | 0.45 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · IE00BDQZN667 · IE00BDQZN6671
RebalixIE00BDQZN667 · IE00BDQZN667 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +14.16% | +14.18% | −0.02% |
| 2024 | +17.02% | +17.09% | −0.07% |
| 2023 | +17.73% | +17.65% | +0.08% |
| 2022 | −20.28% | −20.13% | −0.15% |
| 2021 | +21.29% | +21.54% | −0.25% |
Distributions · per share, in CHF
Frequency: semi-annual · last 12 months: 0.2055 CHF (1.05% of NAV) · last ex-date 13 Aug 2026
| Year | Payments | Total (CHF) | Dividend yield |
|---|---|---|---|
| 2026 | 2 | 0.2055 | — |
| 2025 | 2 | 0.2521 | +1.62% |
| 2024 | 2 | 0.2587 | +1.91% |
| 2023 | 2 | 0.1888 | +1.62% |
| 2022 | 2 | 0.1874 | +1.26% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Listing venues
ESMA register (FIRDS) and official exchange lists
No EU listing in the ESMA register.
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE00BDQZN667
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00BDQZN667
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · IE00BDQZN667 · IE00BDQZN6672